RC
OKUR

RBF Capital’s OnKure Therapeutics OKUR Stock Holding History

RBF Capital’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,454
Closed -$49K – 592
2022
Q3 		$49K Hold
1,454
– – ﹤0.01% 514
2022
Q2 		$39K Buy
+1,454
New +$33.8K ﹤0.01% 518

Other funds holding OKUR

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

RBF Capital's OKUR Position: Q4 2022 in Review

RBF Capital sold out of OnKure Therapeutics (OKUR) in Q4 2022, closing a stake of 1,454 shares — an estimated $49K sold.

RBF Capital first reported a position in OKUR in Q2 2022 and held it in 2 quarters. The position peaked at $49K in Q3 2022. 32 funds tracked by Wall St. Rank hold OKUR as of Q4 2022.

  • RBF Capital reported no remaining OnKure Therapeutics position as of Q4 2022 after selling out during the quarter.
  • RBF Capital sold 1,454 OnKure Therapeutics shares in Q4 2022, an estimated $49K.
  • RBF Capital first reported a position in OnKure Therapeutics in Q2 2022 and held it in 2 quarters.
  • RBF Capital's OnKure Therapeutics position peaked at $49K in Q3 2022.
  • 32 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q4 2022.

Based on RBF Capital's 13F filing for Q4 2022, filed 14 Feb 2023.